Ignite Creation Date:
2024-05-06 @ 3:55 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02408016
Status:
TERMINATED
Last Update Posted:
2021-09-13
First Post:
2015-03-31
Brief Title:
Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Pleural Malignant Mesothelioma |
| HLA-A0201 Positive Cells Present |
| Recurrent Non-Small Cell Lung Carcinoma |
| Recurrent Pleural Malignant Mesothelioma |
| Stage III Non-Small Cell Lung Cancer AJCC v7 |
| Stage III Pleural Malignant Mesothelioma AJCC v7 |
| Stage IIIA Non-Small Cell Lung Cancer AJCC v7 |
| Stage IIIB Non-Small Cell Lung Cancer AJCC v7 |
| Stage IV Non-Small Cell Lung Cancer AJCC v7 |
| Stage IV Pleural Malignant Mesothelioma AJCC v7 |
| WT1 Positive |
Keywords: